Damora Therapeutics, Inc. (DMRA)
About Damora Therapeutics, Inc.
Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$209.8M
- Total assets
- $260.5M
- Market cap
- $1.8B
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $1.8B
- Shares outstanding
- 44.9M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 29, 2020
Damora Therapeutics, Inc. (DMRA) Stock Price
- Reported a net loss of $209.8M.
- Trading 13% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Damora Therapeutics, Inc..
Write a review
News about Damora Therapeutics, Inc.
News & sentiment via Polygon.io
Damora Therapeutics, Inc.: frequently asked questions
Is Damora Therapeutics, Inc. an American company?
Damora Therapeutics, Inc. is a US-based company headquartered in Waltham, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Damora Therapeutics, Inc. headquartered?
Damora Therapeutics, Inc. is headquartered in Waltham, Massachusetts, United States.
Is Damora Therapeutics, Inc. publicly traded?
Yes — Damora Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol DMRA on the NASDAQ.
What does Damora Therapeutics, Inc. do?
Damora Therapeutics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
